A drug that targets an overactive immune response may also weaken the gut’s ability to fight harmful bacteria. Understanding where the molecule is helping or not could be important before this pathway is considered for treatment, new research from National Institute of Immunology, New Delhi, has found
Source: The Hindu Science (English)
